Skip to main content
Log in

Type II Crigler-Najjar syndrome with intrahepatic cholestasis

  • Case Reports
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

A 58-year-old Japanese man was admitted to our hospital with appendicitis and marked unconjugated hyperbilirubinemia (11.6 mg/dl). The jaundice worsened following appendectomy, and the directreacting bilirubin increased, probably due to the ceftizoxime administered postoperatively. Bilirubin diglucuronide was the main component of the serum direct-reacting bilirubin (51%) in serum measured by liquid chromatography. Because the discontinuation of ceftizoxime did not markedly improve the jauncice, epomediol, 200 mg tid, was administered orally. There was a marked decrease of serum bilirubin with an increase in the δ bilirubin/(conjugated bilirubin + δ bilirubin) ratio. After improvement of jaundice to below the pre-surgical level (4.4 mg/dl), we analyzed the duodenal bile for bilirubin fractions; those showed a marked reduction in bilirubin diglucuronide and a marked increase in bilirubin monoglucuronide, which was consistent with type II Crigler-Najjar syndrom. A marked increase of bilirubin diglucuronide in serum of this patient during cholestasis suggests that bilirubin conjugation proceeds in this syndrome when excretion of conjugated bilirubin decreases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Roy-Chowdhury J, Wolkoff AW, Arias IM. Hereditary jaundice and disorders of bilirubin metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds.) The metabolic basis of inherited disease, 6th ed. New York: McGraw-Hill, 1989;1367–1408.

    Google Scholar 

  2. Arias IM, Gartner LM, Cohen M, et al. Chronic nonhemolytic unconugated hyperbilirubinemia with glucuronyl transferase deficiency: Clinical, biochemical, pharmacologic, and genetic evidence for heterogeneity. Am J Med 1969;47:395–409.

    Article  CAS  PubMed  Google Scholar 

  3. Adachi Y, Yamamoto T. Hepatic bilirubin conjugating enzymes of man in the normal state and in liver disease. Gastroenterol Jpn 1982;17:235–240.

    CAS  PubMed  Google Scholar 

  4. Gambino RS, Schreiber H. The measurement and fractionation of bilirubin on the auto analyzer by the method of Jendrassik and Grof. In: Automation in analytical chemistry, Technicon Symposia. New York: Mediad, 1964;54-1–54-11.

    Google Scholar 

  5. Adachi Y, Inufusa H, Yamashita M, et al. Clinical application of serum bilirubin fractionation by simplified liquid chromatography. Clin Chem 1988;34:385–388.

    CAS  PubMed  Google Scholar 

  6. Sundberg MW, Lauff JL, Weiss JS, et al. Estimation of unconjugated, conjugated, and “delta” bilirubin fractions in serum by use of two coated thin films. Clin Chem 1984;30:1314–1317.

    CAS  PubMed  Google Scholar 

  7. Yamashita M, Adachi Y, Yamamoto T. Analysis of bilirubin conjugates in human bile by column liquid chromatography. J Chromat 1986;375:386–391.

    CAS  Google Scholar 

  8. Yamashita M, Adachi Y, Yamamoto T. Analysis of bilirubin conjugates in human bile by column liquid chromatography. Changes in their composition in hepatobiliary diseases. J Gastroenterol Hepatol 1987;2:181–190.

    CAS  Google Scholar 

  9. Sherker AH, Heathcote J. Acute hepatitis in Crigler-Najjar syndrome. Am J Gastroenterol 1987;82:883–885.

    CAS  PubMed  Google Scholar 

  10. Miccio M, Orzes N, Lunazzi GC, et al. Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. Biochem Pharmacol 1989;38:3559–3563.

    Article  CAS  PubMed  Google Scholar 

  11. Rodriguez JV, Torres AM, Lunazzi G, et al. Effect of ethinylestradiol and epomediol on bile flow and biliary lipid composition in rat. Biochem Pharmacol 1992;43:1289–1293.

    Article  CAS  PubMed  Google Scholar 

  12. Adachi Y, Inufusa H, Yamashita M, et al. Serum bilirubin fractionation using multilayer film method in hepatobiliary diseases in comparison with high performance liquid chromatography. Gastroenterol Jpn 1987;22:633–639.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kagita, A., Adachi, Y., Kambe, A. et al. Type II Crigler-Najjar syndrome with intrahepatic cholestasis. J Gastroenterol 29, 214–217 (1994). https://doi.org/10.1007/BF02358686

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02358686

Key words

Navigation